Re: New Apabetalone Publication in Clinical Epigenetics

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Cabel

Rank: Treasurer [?]

Points: 1655 [?]

Votes: 16 Score: 2.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New Apabetalone Publication in Clinical Epigenetics

in response to

New Apabetalone Publication in Clinical Epigenetics

BearDownAZ

posted on Jul 12, 2019 05:58PM

I like the conclusion!

Inhibition of inflammatory and adhesion molecule gene expression by apabetalone is predicted to contribute to MACE reduction in the phase III BETonMACE trial.

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply